CPG Sec. 315.100 Illegal Interstate Commercial Shipment of Dentures (CPG retitled and revised 5/19/2005)

Issue Date: May 19, 2005
Issued by: Center for Devices and Radiological Health
Topic(s): Investigation & Enforcement, Dental
Status: Final

CPG Sec. 315.100 Illegal Interstate Commercial Shipment of Dentures (CPG retitled and revised 5/19/2005)

This compliance policy guide describes policies regarding how FDA will handle the illegal interstate commercial shipment of dentures.

Download the Guidance Document

webmaster2026-08-05T19:00:04+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.